2024-11-11T13:51:19-06:00 2023-12-31 871353108 EISNER ADVISORY GROUP LLC 111 WOOD AVENUE SOUTH ISELIN NJ 088302700 990EZ 2023-01-01 473068376 CENTER OF EXCELLENCE FOR ENGINEERING BIOLOGY INC CENT 4438441309 33 PARK PLACE 191 NEW YORK NY 10007 ANDREW HESSEL TREASURER & CHAIRMAN 4438441309 2024-11-06 1 1 DOUGLAS TAPP P00200641 7322437000 2023 2024-10-15 13:58:12Z X X WWW.ENGINEERINGBIOLOGYCENTER.ORG X X 16 X 0 16 16 3157 784 25387 29328 -29312 214911 0 185599 X 137581 124066 77666 61533 215247 185599 336 0 214911 185599 X THE CENTER OF EXCELLENCE FOR ENGINEERING BIOLOGY, INC. (THE ORGANIZATION") IS DEDICATED TO SUPPORTING RESEARCH, EDUCATION AND ETHICS IN THE EMERGING BIOLOGICAL FIELD OF GENOME-SCALE ENGINEERING AND DISCOVERY. THE ORGANIZATION'S GOAL IS TO ADVANCE GENOME-SCALE ENGINEERING TO ADDRESS IMPORTANT GLOBAL CHALLENGES FACING HUMANITY IN THE FIELDS OF SCIENCE AND MEDICINE. THE ORGANIZATION INTENDS TO USE ITS FUNDS PRIMARILY TO: (I) COORDINATE AND SUPPORT THE FORMATION AND WORK OF MULTI-INSTITUTIONAL AND INTERDISCIPLINARY RESEARCH TEAMS TO WORK IN A HIGHLY INTEGRATED FASHION ON GP-WRITE AND RELATED RESEARCH PROJECTS, (II) ENCOURAGE TIMELY AND DETAILED CONSULTATION AMONG DIVERSE MEMBERS OF THE SCIENTIFIC AND POLICY COMMUNITIES, INCLUDING REGARDING THE ETHICAL, LEGAL AND SOCIAL IMPLICATIONS (ESLI) OF GENOME EDITING TECHNOLOGY, AND (III) DEVELOP AND PROVIDE PUBLIC EDUCATION AND TRAINING IN AN OPEN SOURCE, FULLY AUTOMATED PLATFORM TO SUPPORT THE SHARING OF KNOWLEDGE AND LARGE-SCALE POOLING OF DATA. 0 0 0 AMY SCHWARTZ PRESIDENT / DIRECTOR 30.00 0 0 0 GEORGE CHURCH DIRECTOR 1.00 0 0 0 ANDREW HESSEL TREASURER AND CHAIRMAN 2.00 0 0 0 FARREN ISAACS DIRECTOR 2.00 0 0 0 TODD PETERSON DIRECTOR 1.00 0 0 0 X 0 0 0 0 0 0 0 0 0 0 0 0 0 0 NY ANDREW HESSEL 2 SPRINGHILL DR CAZADERO CA 95421 4438441309 0 0 0 0 0 0 0 0 0 0 0 NONE NONE 1 X 0 18750 138725 47475 0 204950 18750 138725 47475 204950 184455 20495 204950 41777 0.10000 0.25290 X CENTER OF EXCELLENCE FOR ENGINEERING BIOLOGY, INC. IS RECOGNIZED AS AN ORGANIZATION DESCRIBED IN SECTION 501(C)(3). THE ORGANIZATION RECEIVED AT LEAST 33 1/3 PERCENT OF ITS SUPPORT FROM GOVERNMENTAL UNITS REFERRED TO IN SECTION 170(C)(1), FROM CONTRIBUTIONS MADE BY THE GENERAL PUBLIC OR FROM A COMBINATION OF THESE SOURCES FROM 2017 - 2021. IN TAXABLE YEARS 2018, 2019, 2020, 2021 AND 2022, IN THE AGGREGATE, THE ORGANIZATION DOES NOT RECEIVE AT LEAST 33 1/3 PERCENT OF ITS SUPPORT FROM GOVERNMENTAL UNITS REFERRED TO IN SECTION 170(C)(1), FROM CONTRIBUTIONS MADE BY THE GENERAL PUBLIC OR FROM A COMBIATION OF THESE SOURCES. HOWEVER, THE ORGANIZATION STILL MEETS THE 33 1/3 PERCENT SUPPORT TEST FOR TAXABLE YEAR 2022 BASED ON THE AGGREGATE SUPPORT RECEIVED FOR TAXABLE YEARS 2017 THROUGH 2021. IN TAXABLE YEARS 2019, 2020, 2021, 2022 AND 2023, IN THE AGGREGATE, THE ORGANIZATION DOES NOT RECIEVE AT LEAST 33 1/3 PERCENT OF ITS SUPPORT FROM GOVERNMENTAL UNITS REGERRED TO IN SECTION 170(C)(1), FROM CONTRIBUTIONS MADE BY THE GENERAL PUBLIC OR FROM A COMBINATION OF THESE SOURCES. THE ORGANIZATION DOES NOT MEET THE 33 1/3 PERCENT SUPPORT TEST FOR TAXABLE YEAR 2023.THE ORGANIZATION MEETS THE FACTS AND CIRCUMSTANCES TEST FOR TAXABLE YEAR 2023 AND FOR TAXABLE YEAR 2024 (THE IMMEDIATELY SUCCEEDING TAXABLE YEAR) BASED ON THE CONSIDERATION OF OTHER FACTORS, INCLUDING THOSE LISTED IN PARAGRAPHS (F)(3)(III)(A) THROUGH (F)(3)(III)(E) OF IRC SECTION 1.170A-9.THE ORGANIZATION MAINTAINS A CONTINUOUS PROGRAM FOR SOLICITATION OF FUNDS INCLUDING MAINTAINING A WEBSITE AND VARIOUS METHODS OF ADVERTISING. ADDITIONALLY, THE BOARD WORKS TO ESTABLISH STRATEGIC RELATIONSHIPS WITH PHILANTHROPIC, ACADEMIC, INDUSTRIAL AND GOVERNMENTAL PARTNERS. THE BOARD CONSISTS OF A DIVERSE GROUP OF MEMBERS, WHICH INCLUDES EXPERTS IN THE LIFE SCIENCES FIELD, CONSULTING, INVESTING, LAW, AND PUBLIC OUTREACH. THE CENTER OF EXCELLENCE FOR ENGINEERING BIOLOGY, INC. (THE ORGANIZATION") PROGRAMS BENEFIT THE ENTIRE WORLD'S POPULATION. THE ORGANIZATION SUPPORTS RESEARCH, EDUCATION AND ETHICS IN THE BIOLOGICAL FIELD OF GENOME-SCALE ENGINEERING AND DISCOVERY. THE ORGANIZATION'S GOAL IS TO ADVANCE GENOME-SCALE ENGINEERING TO ADDRESS IMPORTANT GLOBAL CHALLENGES FACING HUMANITY IN THE FIELDS OF SCIENCE AND MEDICINE. IN ORDER TO UNDERSTAND THE HUMAN GENOME AND THE BENEFITS TO HUMANITY THAT CAN BE OBTAINED FROM THIS KNOWLEDGE, THE ORGANIZATION IMPLEMENTED THE GENOME PROJECT -WRITE (GP-WRITE), WHICH IS AN OPEN, INTERNATIONAL RESEARCH PROJECT LED BY A MULTIDISCIPLINARY GROUP OF SCIENTIFIC LEADERS WHO WILL OVERSEE A REDUCTION IN THE COSTS OF ENGINEERING AND TESTING LARGE GENOMES IN THE CELL LINES MORE THAN 1,000-FOLD WITHIN TEN YEARS. WRITING DNA CODE REMAINS LIMITED, WHICH RESTRICTS THE ABILITY TO UNDERSTAND AND MANIPULATE BIOLOGICAL SYSTEMS. GP-WRITE WILL ENABLE SCIENTISTS TO MOVE BEYOND OBSERVATION TO ACTION, AND FACILITATE THE USE OF BIOLOGICAL ENGINEERING TO ADDRESS MANY OF THE GLOBAL PROBLEMS FACING HUMANITY SUCH AS HOW TO MOVE FROM A CARBON-BASED ECONOMY TOWARDS A BIOLOGICAL ONE THAT IS SUSTAINABLE AND HOW TO FURTHER ADVANCE CURES FOR DISEASE. ADDITIONALLY, OTHER BENEFITS THAT MAY BE DERIVED FROM GP-WRITE INCLUDE GROWING TRANSPLANTABLE HUMAN ORGANS, POTENTIALLY ENABLING THOUSANDS OF PATIENTS ACROSS THE GLOBE WHO DIE WAITING FOR DONATED ORGANS, ENGINERING IMMUNITY TO VIRUSES IN CELL LINES, ENGINEERING CANCER RESISTANCE INTO NEW THERAPEUTIC CELL LINES, ENABLING HIGH-PRODUCTIVITY COST-EFFICIENT VACCINES AND PHARMACEUTICAL DEVELOPMENT USING HUMAN CELLS AND ORGANOIDS THAT MAKES PRECISION MEDICINE MORE AFFORDABLE AND UNIVERSAL. FORM 990-EZ, PART I, LINE 16 - OTHER EXPENSES DESCRIPTION: ADVERTISING AND PROMOTION. AMOUNT: 520. DESCRIPTION: COMPUTER AND INTERNET. AMOUNT: 217. DESCRIPTION: INSURANCE. AMOUNT: 1,880. DESCRIPTION: OFFICE EXPENSES. AMOUNT: 156. DESCRIPTION: TAXES. AMOUNT: 25. DESCRIPTION: SOFTWARE & SUBSCRIPTIONS. AMOUNT: 2,206. DESCRIPTION: DUES & SUBSCRIPTIONS. AMOUNT: 250. DESCRIPTION: DEPRECIATION. AMOUNT: 20,133. TOTAL TO FORM 990-EZ, LINE 16: 25,387. FORM 990-EZ, PART II, LINE 24 - OTHER ASSETS DESCRIPTION: OTHER DEPRECIABLE ASSETS. BEG. OF YEAR AMOUNT: 77,666. END OF YEAR AMOUNT: 61,533. FORM 990-EZ, PART II, LINE 26 - OTHER LIABILITIES DESCRIPTION: ACCRUED EXPENSES. BEG. OF YEAR AMOUNT: 336. END OF YEAR AMOUNT: 0. THE ORGANIZATION DID NOT, DURING THE YEAR, RECEIVE ANY FUNDS, DIRECTLY,OR INDIRECTLY, TO PAY PREMIUMS ON A PERSONAL BENEFIT CONTRACT.THE ORGANIZATION, DID NOT, DURING THE YEAR, PAY ANY PREMIUMS, DIRECTLY,OR INDIRECTLY, ON A PERSONAL BENEFIT CONTRACT.